Study: RWD not ready for postapproval prime time

Regulatory NewsRegulatory NewsBiologics/ biosimilars/ vaccinesClinical TrialsHealth Authority meeting and communication strategyNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy